Category Archives: News & updates

ABILIFY: Generic name Aripiprazole Antipsychotic second generation Indications Schizophrenia, Bipolar Disorder Dosage forms 2mg, 5 mg, 10mg, 15mg, 20mg, 30 mg Maximum daily dose Adults 30 mg Children 30 mg 10-17 yrs old Half life 75 Hours Side effects Nausea, … Continue reading →

I experienced an interesting confluence of events the other day. My 11-year-old son has been finding out about the great power of online information. Although we limit his access to assistance with homework, he is already a digital whiz kid … Continue reading →

Bipolar disorder causes havoc in patients’ lives. Even in the best of circumstances, successful treatment is challenging. Treatment targets constantly shift; patients are frequently nonadherent; and comorbidity is the rule, not the exception. Diagnosis of bipolar disorder is often difficult. … Continue reading →

Astute readers of obituaries know that “died unexpectedly” is a common euphemism for “died by suicide”. The family and friends of suicide victims are often reluctant to openly discuss the cause of death because of profound sadness, sense of privacy, … Continue reading →

Limitation of access to lethal methods used for suicide—so-called means restriction—is an important population strategy for suicide prevention. Many empirical studies have shown that such means restriction is effective. Although some individuals might seek other methods, many do not; when … Continue reading →